| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |